Iovance Biotherapeutics, Inc. (IOVA) NASDAQ
3.30
-0.13(-3.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 975.55M |
| Enterprise Value | 860.92M |
| P/E Ratio | -3.43 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 4.15 |
| Price/Book Ratio | 1.92 |
| Enterprise/Revenue | 3.72 |
| Enterprise/EBITDA | -2.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.48 |
| Operating Margin | -1.53 |
Management Effectiveness
| Return On Assets | -0.43 |
| Return On Equity | -0.55 |
Income Statement
| Revenue | 263.5M |
| Revenue/Share | 0.65 |
| Gross Profit | 256.22M |
| EBITDA | -357.11M |
| Net Income | -390.98M |
| Diluted EPS | -1.09 |
Balance Sheet
| Total Cash | 296.98M |
| Total Cash/Share | 0.73 |
| Total Debt | 48.44M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 3.2 |
| Book Value Per Share | 1.72 |
Price History
| 52-Week Change | 8.91 |
| 52-Week High | 5.63 |
| 52-Week Low | 1.64 |
| Moving Average 50 Days | 3.41 |
| Moving Average 200 Days | 2.6 |
Statistics
| Average Volume | 14.97M |
| Shares Outstanding | 331.69M |
| % Held by Institutions | 71.86 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | September 26, 2013 |
